Screener
Xenon Pharmaceuticals XENE Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $6.42M.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's total debt?
- Xenon Pharmaceuticals (XENE) reported total debt of $6.42M in Q2 2026.
- How has Xenon Pharmaceuticals's total debt changed year-over-year?
- Xenon Pharmaceuticals's total debt decreased by 26.4% year-over-year, from $8.72M to $6.42M.
- What is the long-term trend for Xenon Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total debt has grown at a 19.1% compound annual growth rate (CAGR), from $3.32M to $7.94M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Xenon Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude